Warren R. J. D. Galloway
Molecular Biology · 2010–2011
A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 8 citations into it
- Organic Chemistry — 6 citations into it
Whom Warren R. J. D. Galloway trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Warren R. J. D. Galloway overall
Papers from Warren R. J. D. Galloway's perspective
Ordered by how strongly the researchers Warren R. J. D. Galloway trusts endorse each paper. Same corpus, a different order for every researcher.
- Escape from flatland: increasing saturation as an approach to improving clinical success.
- Drugs for bad bugs: confronting the challenges of antibacterial discovery (Nature reviews. Drug discovery)
- A planning strategy for diversity-oriented synthesis. (Angewandte Chemie)
- Structural diversity of organic chemistry. A scaffold analysis of the CAS Registry.
- Natural products as sources of new drugs over the last 25 years. (Journal of Natural Products)
- Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery (Journal of chemical information and computer sciences)
- A new multipoint method for genome-wide association studies by imputation of genotypes (Nature Genetics)
- Active genes are tri-methylated at K4 of histone H3 (Nature)
- Bacterial flagellin is a dominant antigen in Crohn disease. (Journal of Clinical Investigation)
- A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 (Nature Genetics)
Their papers
- Drug discovery: A question of library design (2011) — 100 citations
- Quorum sensing in Gram-negative bacteria: small-molecule modulation of AHL and AI-2 quorum sensing pathways. (2011) — 620 citations
- Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. (2010) — 700 citations